BICO Group AB (publ) (STO: BICO)

Market Cap	3.14B
Revenue (ttm)	2.42B
Net Income (ttm)	-1.55B
Shares Out	70.57M
EPS (ttm)	-21.93
PE Ratio	n/a
Forward PE	18.64
Dividend	n/a
Ex-Dividend Date	n/a

Volume	102,283
Open	44.48
Previous Close	44.48
Day's Range	43.84 - 45.20
52-Week Range	23.38 - 72.30
Beta	2.34
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 30, 2024

About BICO Group AB

BICO Group AB (publ) operates as a bioconvergence company in North America, Europe, Asia, and internationally. It operates through three segments: Bioprinting, Biosciences, and Bioautomation. The Bioprinting segment offers products, solutions, and services that enable proliferation of 3D cell culture and 3D printing. The Biosciences segment provides instruments that enable the handling of cells and rare samples, and rapid transfer of liquids and reagents, as well as downstream analysis platforms. The Bioautomation segment offers end-to-end prod...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2016
• Employees: 880
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: BICO

Financial Performance

In 2023, BICO Group AB's revenue was 2.40 billion, an increase of 3.35% compared to the previous year's 2.33 billion. Losses were -1.98 billion, 138.1% more than in 2022.